AzTrials
AzTrials

MalnutritionFLNS_SAMNCT02907424

Comparison of a Locally Produced RUTF With a Commercial RUTF in the Treatment of SAM

A study testing 2 months of treatment in people with Malnutrition and Children, run by Institut de Recherche pour le Developpement at 1 site in Cambodia.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

In order to make Cambodia independent from importing a product for the treatment and prevention of malnutrition, UNICEF, DFPTQ Fisheries Administration and IRD have started a collaboration for the development of a range of products for the treatment and prevention of malnutrition. Read more about this study

Who is it for?
Ages 6 months to 5 years
Conditions the study is for
Malnutrition, Children, Treatment
What is being tested?
2 months of treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
120 participants
Where
1 siteCambodia
Study dates
1 Apr 2016to May 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 5 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • discharged from hospital after admission for SAM
  • WHZ <2.8 Z-score or MUAC<11.5 cm
  • no complications
  • passing the appetite test

Who cannot join

  • <6 mo of age
  • complications related to SAM

Trial locations and contacts

1 site in 1 country.

Cambodia1 site
  • Department of Fisheries Post-harvest Technologies and Quality Control, Fisheries Administration

    Phnom Penh

Other trials in Cambodia

About this study

Official title: Comparison of a Locally Produced RUTF With a Commercial RUTF in the Treatment of SAM in Cambodia

In order to make Cambodia independent from importing a product for the treatment and prevention of malnutrition, UNICEF, DFPTQ Fisheries Administration and IRD have started a collaboration for the development of a range of products for the treatment and prevention of malnutrition. To reduce costs of the product, and to adapt the taste to local circumstances, the protein source of the usual RUTF (milk powder) has been changed to fish (Trey Riel). The main objective of this sub-study is to test the efficacy of the newly developed RUTF on the recovery of children suffering from severe acute malnutrition. As comparison, the current treatment of SAM with BP-100 will be used.

Being tested
2 months of treatment
Medical subject headings
Malnutrition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 2 months of treatmentDietary supplement

    standard 2 months of treatment

Study groups in NCT02907424
Study groupRoleWhat they receive
BP-100Active comparatorstandard treatment
Receives: Dietary Supplement: 2 months of treatment
Num TreyExperimentallocally produced RUTF
Receives: Dietary Supplement: 2 months of treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. weight gain

    weight gain in g/kg/day

    Measured: 2 months

Secondary outcomes (2)
  1. body composition

    changes in body composition obtained from skinfold thickness measurements over the treatment period

    Measured: 2 months

  2. Fatty Acid composition

    changes in serum concentrations of fatty acids over the intervention period

    Measured: 2 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Sep 2016 (estimated)
  2. Study start1 Apr 2016
  3. Primary completion15 Jan 2017
  4. Study completionMay 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Masking
Single blind
Who is masked
Investigator
Enrolment
120 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02907424
Sponsor's protocol ID
IRD_UNICEF_DFPTQ_SAM
Acronym
FLNS_SAM
Status last verified
May 2018
First submitted
12 Sep 2016
Last updated
16 May 2018
Results posted
No
Data monitoring committee
No
Individual data sharing
Yes

Publications

  • Sigh S, Lauritzen L, Wieringa FT, Laillou A, Chamnan C, Stark KD, Roos N. Changes in polyunsaturated fatty acids during treatment of malnourished children may be insufficient to reach required essential fatty acid levels - A randomised controlled trial. Clin Nutr. 2023 Sep;42(9):1778-1787. doi: 10.1016/j.clnu.2023.08.003. Epub 2023 Aug 6.

    PubMed 37572581
  • Sigh S, Lauritzen L, Wieringa FT, Laillou A, Chamnan C, Angkeabos N, Moniboth D, Berger J, Stark KD, Roos N. Whole-blood PUFA and associations with markers of nutritional and health status in acutely malnourished children in Cambodia. Public Health Nutr. 2020 Apr;23(6):974-986. doi: 10.1017/S1368980019003744. Epub 2020 Jan 24.

    PubMed 31973779

Questions about this trial

What is this clinical trial studying?

A study testing 2 months of treatment in people with Malnutrition and Children, run by Institut de Recherche pour le Developpement at 1 site in Cambodia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 May 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Cambodia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

weight gain (time frame: 2 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02907424, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in